Amorepacific Ventures

Amorepacific Ventures

Amorepacific Ventures launched in 2018 as the early-stage investment arm of the Amorepacific Group, the Seoul-based cosmetics giant founded by the Suh family. Chairman Suh Kyung-bae, whose late father Suh Sung-whan pioneered the introduction of French beauty techniques to South Korea, established the vehicle to gain direct exposure to next-generation consumer, health, and technology companies. The family’s wealth stems entirely from Amorepacific Group and its portfolio of brands including Sulwhasoo, Laneige, and Innisfree, which generate the revenue that funds the venture operation. The firm operates from a dual-headquarters structure with a core team in Seoul and a sourcing presence in San Francisco. The fund’s mandate spans early and growth-stage ventures in beauty technology, digital health, artificial intelligence, and enterprise software, with a preference for Seed and Series A checks. Geographic deployment concentrates on South Korea and the United States, with selective activity in Southeast Asia. Rather than operating as a pure financial investor, Amorepacific Ventures anchors its strategy in a corporate venture model by providing portfolio companies access to the parent group’s R&D labs, manufacturing infrastructure, and distribution channels across 40 global markets. Confirmed portfolio positions include Tailor, a Korean AI-powered personalized beauty platform, and an investment in the genomic skincare startup Skinome (per AVCJ, 2023). The firm structure allows both direct equity and SPV-based co-investments alongside established US and Korean venture funds. Publicly available data places the fund’s committed capital at approximately $100 million (per AVCJ, 2023). The investment team, led by Head Kim Yun-kyoung, operates with a lean structure characteristic of a family-funded strategic vehicle. In April 2024, the firm promoted Kim to lead its expanded US deal-sourcing efforts from the San Francisco office. The parent group maintains a distinct philanthropic foundation established in 1954, famously associated with the recovery and repatriation of the Moon Jar, a Joseon Dynasty artifact repatriated to South Korea in 2023, though this entity operates separately from the venture arm. The investment vehicle does not participate in LP commitments to external fund managers, focusing entirely on direct equity deployments. The firm's structural differentiator lies in its single-family backing embedded within a publicly traded corporate shell. This allows Amorepacific Ventures to combine the patient capital timeline of a family office with the distribution muscle of a global CPG company. For a beauty-tech founder, an investment from this vehicle represents a potential integration partnership with the dominant force in Asian beauty, rather than a purely financial transaction. This model — a single-industry CVC fully capitalized by family-controlled wealth — distinguishes it from both traditional conglomerate venture arms and generalist multi-family offices in the region.